Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis

Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2013, Vol 2, Issue 2

Abstract

A lethal autosomal recessive genetic disease, cystic fibrosis (CF) is most common in Caucasians and the prevalence varies with the ethnic origin of the population. Patients with CF lack adequate levels of the CF transmembrane conductance receptor (CFTR) protein, a chloride channel necessary for normal function of the lung, pancreas, liver and other organs. Nonsense (premature stop codon) mutations in mRNA for the CFTR cause CF in approximately 10% of patients. Ataluren, a protein restoration therapy, is designed to promote the translational read-through of premature stop codons that helps to overcome the nonsense mutation and enable the production of a full-length, functional CFTR protein. Insertion of a near cognate amino acid at a premature stop codon allows the protein translation to continue until one of the several stop codons normally present at the ends of mRNA transcript is reached and properly utilized. It is a “corrector” drug specific for type I mutation defects. Ataluren is a novel, orally bioavailable drug that addresses the molecular basis of the disease. Phase III Clinical trials have shown it to be efficacious and well tolerated. It represents a breakthrough in the pharmacological advances for a rare genetic disease.

Authors and Affiliations

Suruchi Aditya*| Asstt. Prof, Department of Pharmacology, Dr. Harvansh Singh Judge Institute of Dental Sciences, Panjab University, Chandigarh, India, Surya Kant Mathur| Professor, Department of Pediatrics, MM Institute of Medical Sciences, Mullana, Ambala, India

Keywords

Related Articles

MULTIDRUG LOADED GASTRORETENTIVE FILMS FOR THE TRATMENT OF H. PYLORI INFECTION

The objective of the present work was to develop innovative gastro retentive formulation based on mucoadhesive patch systems using the solvent casting technique, allowing a final structure with improved cohesion by mucoa...

SIGNIFICANCE OF PREFORMULATION STUDIES IN DESIGNING, FABRICATING FOR PHARMACEUTICAL DOSAGE FORMS

Prior to development of any formulations the physiochemical properties of drug should be known to the developer. Preformulation studies have a significant part to play in anticipating formulation problems and identifying...

Observational Study on Nephrotoxicity, Hepatotoxicity and Electrolytes Imbalance Induced by Amphotericin B in Kala-Azar Patients

Leishmaniasis is a disease caused by protozoan parasites that belong to the genus Leishmania and is transmitted by the bite of certain species of sand fly (subfamily Phlebotominae). It is the second largest parasitic kil...

USEFULLNESS OF THE MPB-64 GENE BASED STOOL PCR FOR THE DIAGNOSIS OF PULMONARY TUBERCULOSIS IN PEDRIATIC PATIENTS

Purpose: Pedriatic pulmonary tuberculosis diagnosis is challenging because young children not able to spontaneously produce sputum. Diagnosis stool for tuberculosis dna from swallowed sputum may diagnose pulmonary tube...

UTILIZATION PATTERN AND MEDICATION ADHERENCE OF ORAL ANTI-DIABETIC MEDICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN RURAL AREAS OF KARNATAKA, SOUTH INDIA.

Objective: To assess the utilization pattern and medication Adherence of oral anti-diabetic medications among patients with type 2 diabetes mellitus in rural areas of Bangalore East. Methodology: A prospective observatio...

Download PDF file
  • EP ID EP1649
  • DOI -
  • Views 394
  • Downloads 24

How To Cite

Suruchi Aditya*, Surya Kant Mathur (2013). Ataluren: A Novel Targeted Therapeutic Approach for the Treatment of Cystic Fibrosis. Journal of Biomedical and Pharmaceutical Research, 2(2), 21-25. https://europub.co.uk/articles/-A-1649